(1)
Darmadi, D.; Sungkar, T.; Pakpahan, C.; Surja, S. S. An Efficacy and Safety Comparison of Regorafenib and Nivolumab in Unresectable Hepatocellular Cancer Patients: A Systematic Review. ama 2024, 53, 46-58.